Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Mar 23 2024
Business
Mar 23 2024
3 min read

Press Release Mar 23 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 23, 2024, titled "Zydus receives tentative approval from USFDA for Letermovir Tablets, 240 mg and 480 mg".

View Attachment